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Abstract
Several case reports and retrospective studies have reported a temporal association between RBC 
transfusions and necrotizing enterocolitis. In this article, we summarize the clinical evidence and 
biological plausibility of the association between RBC transfusions and NEC. We also review the 
clinical presentation, management, and outcomes in infants with “transfusion-associated” NEC.
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Premature infants are a heavily-transfused population, with more than half of all very low 
birth weight infants (VLBW) infants receiving one or more red blood cell (RBC) 
transfusions during their hospital stay (1). In recent years, there has been renewed interest in 
potential adverse events following the administration of blood products, particularly in the 
context of the reported association between RBC transfusions and necrotizing enterocolitis 
(NEC) (2, 3). Several case reports and retrospective studies show that up to a third of all 
VLBW infants who develop NEC may have received one or more RBC transfusions in the 
preceding 24-72 hours prior to onset of NEC (4-18). In this article, we evaluate the quality 
of evidence and biological plausibility of this association, and review the clinical 
presentation and management of “transfusion-associated” NEC.
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Do RBC transfusions cause NEC in premature infants?
Increasing clinical evidence indicates that the answer to this question may be in the 
affirmative, although causality is yet to be demonstrated. The association between RBC 
transfusions and NEC was first noted by McGrady et al. in 1987, who investigated an 
outbreak of 33 cases of NEC in their neonatal intensive care unit (NICU) and reported that 
RBC transfusions increased the risk of NEC (odds ratio 15.1, confidence interval (CI) 
2.59-92.51). In 1998, Bednarek et al. (6) compared transfusion practices in VLBW infants in 
six NICUS and in multivariate analysis, noted that NICUs with fewer transfusions had a 
lower incidence of NEC (adjusted odds ratio 0.3, CI 0.1-0.8) than in those with a larger 
number of transfusions (odds ratio 1.1, CI 0.5-2.2). Since then, sporadic cases of 
“transfusion-associated” NEC continued to be recognized by clinicians, as exemplified by 
the case reports by Agwu and Narchi (19), and Short et al. (20).
In recent years, the association between RBC transfusions and NEC has received significant 
investigative attention. Since 2006, several retrospective studies led by Mally (14), 
Perciaccante (21), Holder (18), Christensen (5), Josephson (7), Carter (8), Couselo (9), Paul 
(10), Singh (11), El-Dib (12), Blau (13), Ghirardello (15), Stritzke (16), and Wan-Huen (17) 
have been published. Although these study cohorts show important differences in 
demographics, severity of illness, age of RBCs, and the baseline incidence of NEC, several 
common elements are seen (Table 1): (a) of all the cases of NEC, 25-40% may have 
received an RBC transfusion in the preceding 2-48 hours, generally about 12 hours, prior to 
onset of NEC (4-18); (b) neonates with transfusion-associated NEC are generally born at an 
earlier gestation than those who develop NEC unrelated to transfusion (4-18); (c) 
transfusion-associated NEC has a delayed onset at 3-5 weeks of postnatal age, whereas those 
with NEC unrelated to transfusion are generally younger (1-3 weeks old) (4-11, 13-18); (d) 
neonates with transfusion-associated NEC have had one or more previous RBC transfusions 
(5, 10); and (e) the age of the blood transfused (days since donor draw) does not differ 
significantly between those with transfusion-associated NEC, those who developed NEC 
without a history of a temporally-proximate transfusion, and matched controls who 
underwent transfusion but did not develop NEC (5, 7, 10); (f) infants who developed NEC 
following a transfusion may have had a higher acuity of illness with higher odds of having 
had a patent ductus arteriosus (pooled odds ratio 2.68, CI 1.81–3.97) (7, 13, 14, 16, 18, 22) 
and of being ventilated at the time of diagnosis (pooled odds ratio 3.16, CI 1.60–6.22) (7, 
12-14, 18, 22).
In contrast to the other studies, Harsono et al. (23) detected a protective effect of RBC 
transfusions against NEC. They reviewed the clinical course of 2123 infants (birth weight 
966g ± 265 grams) to investigate whether VLBW infants who receive RBC transfusions 
beyond postnatal age of ≥ 28 days were at increased risk of NEC in a 48 hour period 
following the transfusion. In their cohort, 43 (2%) infants developed NEC beyond postnatal 
day 28, and 26 of these 43 infants (60%) developed NEC within 48 hours of receiving a 
blood transfusion. After controlling for birth weight, gender, and a history of umbilical 
artery catheter insertion, infants who received a transfusion were less likely to develop NEC 
than those who did not receive a blood transfusion (OR= 0.30; 95% CI: 0.15-0.60). The 
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authors concluded that RBC transfusions may protect against ‘late-onset’ NEC by reducing 
the effects of chronic anemia and consequent tissue hypoxia.
Mohamed and Shah (22) recently published a meta-analysis of observational data from 
studies on transfusion-associated NEC. They confirmed increased odds of NEC within a 48-
hour period following an RBC transfusion. Meta-analysis on 5 studies that reported 
unadjusted estimates of exposure to transfusion in previous 48 hours and NEC (5, 10-12, 21) 
showed increased odds of NEC after recent transfusion (pooled odds ratio 3.91, CI: 2.97–
5.14; I2 = 58%). Meta-analysis of 4 studies (10, 16, 17, 23) that reported adjusted estimates 
revealed a similar but lower risk of NEC (pooled adjusted odds ratio 2.01, CI: 1.61–2.50; I2 
= 91%). Exclusion of Harsono et al. (23) from meta-analysis led to disappearance of 
statistical heterogeneity (pooled odds ratio 2.48, CI: 1.97–3.12, I2 = 0).
Can RBC transfusions cause NEC in premature infants?
Although transfusion-associated NEC has no proven pathogenic mechanism, several 
plausible explanations have been proposed. These include immaturity of the splanchnic 
vascular bed, immune mechanisms similar to those seen in transfusion-related acute lung 
injury (TRALI), re-oxygenation injury in the anemic gut, and the effects of stored RBCs.
Host immaturity
Several studies had demonstrated immaturity of the vascular autoregulatory responses in the 
neonatal gastrointestinal tract, potentially placing the infant at increased risk of gut mucosal 
injury. Using newborn piglets, Szabo et al. (24) showed that hypoxia impaired the normal 
post-prandial hyperemic response, decreased arterial oxygen content and gut oxygen 
delivery, but at the same time, increased tissue oxygen extraction. In the clinical setting, 
Krimmel et al. (25) showed that RBC transfusions can dampen the normal postprandial 
increase in mesenteric blood flow in premature infants, particularly in those with a birth 
weight <1250 grams. In another study, Gupta et al. (26) demonstrated that RBC transfusions 
in infants with a hemodynamically-significant ductus arteriosus were associated with 
reduced mesenteric blood flow 4 hours after completion of the transfusion. Besides 
physiological immaturity of the splanchnic vascular bed in the preterm infant, Blau et al. 
(13) suggest that there may be additional biological reasons to explain the occurrence of 
transfusion-associated NEC at approximately 31 weeks of post-menstrual age (PMA). They 
note that this specific PMA coincides with various conditions associated with 
neovascularization and oxygen toxicity, and speculate that the expression of angiogenic 
factors (such as the vascular endothelial growth factor) in the anemic gastrointestinal tract 
may be subject to similar developmental irregularities as in the retina in infants with severe 
anemia (27).
Transfusion-related acute gut injury?
Blau et al. (13) hypothesized that transfusion-associated NEC may also share 
immunological mechanisms with TRALI. TRALI is speculated to result in a two-hit model 
in which host neutrophils are primed by an antecedent illness, followed by passive 
transfusion of biological response mediators such as donor antibodies such as those directed 
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against the human leukocyte antigens (HLA), biologically-active lipids, free hemoglobin, 
red cell membrane fragments, and inflammatory cytokines present in stored blood (28). 
Similar factors may cause mucosal injury in the premature intestine, which displays a 
developmentally-regulated pro-inflammatory bias with exaggerated immune responses to 
bacterial and/or nutritional antigens (29, 30). Anti-HLA antibodies have been detected in 
some (31), but not all (13), studies on premature infants who were transfused and developed 
NEC. Paul et al. (10) reported that 83% donors in their cases of transfusion-associated NEC 
were male, who were less likely to carry anti-HLA antibodies in their blood than female 
donors. Another mechanistic consideration would invoke the presence of free hemoglobin 
(resulting from RBC lysis during storage and/or washing), interacting with additional 
humoral mediator(s) introduced via plasma (28).
Anemia
Studies in animal models demonstrate that anemia can impair splanchnic perfusion and 
increase oxygen extraction as a compensatory mechanism (24), which may lead to anaerobic 
metabolism and accumulation of its by-products such as lactic acid (32). Intestinal vascular 
resistance changes rapidly during transition from fetal to early neonatal life. Anemia can 
impair this normal transition (33), predisposing the developing intestine to hypoxemic-
ischemic gut mucosal injury, and possibly, to NEC (32). In a recent study, Singh et al. (11) 
investigated the association between anemia and transfusion-associated NEC in a cohort of 
111 preterm infants with confirmed NEC and 222 matched controls. In a multivariate model, 
lower hematocrit was associated with increased odds of NEC (odds ratio 1.10, p=0.01) after 
controlling for other factors. They showed that RBC transfusions had a temporal relationship 
with onset of NEC, where a transfusion within the preceding 24 hours (odds ratio 7.60, 
p=0.001) and 48 hours (odds ratio 5.55, p=0.001) was associated with increased odds of 
developing NEC. This association was no longer significant by 96 hours post- transfusion. 
However, in contrast to this study, the relationship between the severity of the underlying 
anemia and risk of transfusion-related NEC was not evident in other studies, including our 
own (7), and those by Christensen et al. (5), Paul et al. (10), and Blau et al. (13).
In convalescing preterm infants, the most likely reason for a low hematocrit beyond 3-4 
weeks of postnatal age is anemia of prematurity. However, in infants with NEC, other 
etiologies may need to be carefully excluded. Some studies have shown an association of 
NEC with activation of the Thomsen-Friedenreich cryptic T antigen (T-antigen activation) 
on RBCs, causing low-grade hemolysis and anemia in multi-transfused patients who have 
previously received blood from adult donors carrying anti-T antibodies (34). Although the 
pathophysiological significance of T-activation in NEC remains unresolved (35), the 
presence of low-grade smoldering NEC prior to transfusion may be difficult to exclude in 
some patients. Growing preterm infants who are anemic but otherwise stable are usually 
monitored with an expectation of spontaneous improvement in hematocrits. Because anemia 
could manifest in premature infants with myriad presentations (36), non-specific symptoms 
of early NEC such as tachycardia, feeding intolerance, and irritability could be ascribed to 
anemia and treated with a transfusion. In these infants, later development of more obvious 
clinical manifestations of NEC could easily be associated erroneously with the RBC 
transfusion.
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Stored blood
Stored RBCs show well-known ‘storage lesions’ such as reduced deformability, increased 
RBC adhesion and aggregation, and the loss of nitric oxide. Nitric oxide stored in RBCs is 
covalently-bound to cysteine residues of hemoglobin and its gradual release helps maintain 
microvascular perfusion and tissue oxygen delivery. In stored blood, RBCs are rapidly 
depleted of nitric oxide, which correlates with loss of RBC function, and can be associated 
with a paradoxical reduction in oxygen delivery, vasoconstriction, and ischemic injury to the 
intestine (and other organs) (37). Stored RBCs may also have direct pro-inflammatory 
effects such as activation of neutrophils to produce interleukin (IL)-8 and phospholipase A2. 
Transfused blood contains high levels of IL-1, IL-6 and IL-8, which may rise further with 
increasing duration in storage (38).
Is there merit in withholding feeds around the time of transfusion?
So far, two studies have addressed the issue of withholding feeds around the time of 
transfusion (12, 21). After a cluster of cases of transfusion-associated NEC, Perciaccante et 
al. (21) changed from a practice of no disruption of feeding schedules to a practice of 
withholding feedings from 4 hours before the start of the transfusion until 4 hours after the 
completion of the transfusion. Before introducing the practice of withholding feedings, they 
recorded a history of an RBC transfusion in the preceding 48 hours prior to onset of NEC in 
7 out of 18 (38.9%) cases of NEC. Following the change in feeding practices, they did not 
record any cases of NEC that occurred within 48 hrs of an RBC transfusion. These findings 
are similar to those reported by El-Dib et al. (12), who also changed their feeding policy in 
the second half of their study and detected a significant reduction in the incidence of 
transfusion-associated NEC from 5.3% to 1.3% after instituting the policy change.
Do infants with transfusion-associated NEC fare worse than other cases of 
NEC?
In our own study (7), infants with transfusion-associated NEC had a higher frequency of 
surgical intervention and longer duration of stay than those with non-transfusion-associated 
NEC. The overall mortality in NEC/RBC-transfused and NEC/non-RBC-transfused groups 
was similar (10/47, 21% vs. 7/46, 15%, respectively; p=0.45). These results contrast with the 
findings of Stritzke et al. (16), who reported mortality and morbidity data from a large 
cohort of VLBW infants from Canadian Neonatal network. After adjusting for confounding 
factors, no significant differences in mortality/neonatal morbidity were found between the 
two groups. Of all the studies on transfusion-associated NEC, six (5, 12, 13, 16, 18, 21) have 
reported unadjusted estimates of mortality. Meta-analysis of these studies (22) revealed 
higher odds of mortality in patients who had transfusion-associated NEC compared with 
those with NEC not associated with transfusion (pooled odds ratio 1.88, CI 1.35–2.61). 
None of the studies have reported adjusted estimates.
Clinical outcomes in transfusion-associated NEC need careful evaluation because these 
infants were more premature and may have had a higher severity of illness prior to and at the 
time of transfusion (5, 7-13, 15-17, 21), both of which are independent predictors of 
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morbidity and mortality in NEC (29). In our study (7), patients who developed NEC and had 
received one or more transfusions also had a higher incidence of PDA, a higher frequency of 
intraventricular hemorrhage, and more frequent use of central vascular catheters. In our own 
study (7), and in several others (12, 13, 18), infants who developed NEC after a transfusion 
were more likely to be on respiratory support (supplemental oxygen/assisted ventilation) in a 
48 hour-period preceding the onset of NEC.
Conclusion
Based on current clinical evidence, transfusion-associated NEC appears to be a plausible 
clinical entity. However, there is a need for cautious interpretation of data because all the 
studies that have been conducted until date are retrospective, and therefore, susceptible to 
bias and to the effect of confounding variables (39). A large, prospective, multi-center trial 
is needed to evaluate the association between RBC transfusion and NEC, clinical 
characteristics of transfusion-associated NEC, outcomes, and the scientific merit of 
interventions such as withholding feeds before and during PRBC transfusion. Strategies to 
decrease RBC transfusions, such as the use of recombinant erythropoietin or its synthetic, 
longer-acting homologues such as darbepoietin may also be of interest. Other potential 
approaches include repletion of nitric oxide in stored RBCs before transfusion or 
administration of inhaled nitric oxide to at-risk neonates during transfusion (5).
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